Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) reached a new 52-week high and low during trading on Wednesday . The company traded as low as $81.72 and last traded at $81.25, with a volume of 3382 shares traded. The stock had previously closed at $80.34.
A number of analysts have recently commented on the company. Citigroup boosted their price objective on Nu Skin Enterprises from $81.00 to $82.00 and gave the stock a “buy” rating in a research note on Monday, April 30th. Deutsche Bank downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating and set a $77.00 price objective on the stock. in a research note on Friday, April 13th. ValuEngine raised Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research note on Monday, April 2nd. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Wednesday, February 28th. Finally, Stifel Nicolaus boosted their price objective on Nu Skin Enterprises from $50.00 to $57.00 and gave the stock a “sell” rating in a research note on Friday, February 16th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $73.50.
The stock has a market capitalization of $4.49 billion, a PE ratio of 25.06, a price-to-earnings-growth ratio of 2.71 and a beta of 1.34. The company has a quick ratio of 0.75, a current ratio of 1.14 and a debt-to-equity ratio of 0.13.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 13th. Stockholders of record on Friday, May 25th will be given a dividend of $0.365 per share. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Thursday, May 24th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 45.20%.
In related news, General Counsel D Matthew Dorny sold 3,000 shares of the company’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $72.69, for a total transaction of $218,070.00. Following the transaction, the general counsel now directly owns 44,399 shares of the company’s stock, valued at $3,227,363.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Steven Lund sold 81,000 shares of the company’s stock in a transaction on Wednesday, April 4th. The shares were sold at an average price of $75.00, for a total value of $6,075,000.00. Following the transaction, the chairman now directly owns 4,769 shares in the company, valued at $357,675. The disclosure for this sale can be found here. Insiders have sold 121,474 shares of company stock worth $9,039,111 over the last ninety days. 5.20% of the stock is owned by insiders.
Large investors have recently bought and sold shares of the stock. Wolverine Asset Management LLC raised its position in Nu Skin Enterprises by 106.9% during the fourth quarter. Wolverine Asset Management LLC now owns 1,514 shares of the company’s stock valued at $103,000 after buying an additional 23,378 shares during the period. Cerebellum GP LLC acquired a new position in Nu Skin Enterprises during the fourth quarter valued at $124,000. Centaurus Financial Inc. acquired a new position in Nu Skin Enterprises during the first quarter valued at $136,000. Quantbot Technologies LP raised its position in Nu Skin Enterprises by 293.0% during the first quarter. Quantbot Technologies LP now owns 2,071 shares of the company’s stock valued at $152,000 after buying an additional 1,544 shares during the period. Finally, Amundi Pioneer Asset Management Inc. acquired a new position in Nu Skin Enterprises during the fourth quarter valued at $192,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.